Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT03470545 is registered in ClinicalTrials.gov with MyoKardia, Inc. as lead sponsor.

NCT NCT03470545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03470545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Lead sponsor
MyoKardia, Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 29, 2018
Completion date
May 6, 2020
Enrollment
251 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive hypertrophic cardiomyopathy